memo - Magazine of European Medical Oncology

DNA damage repair – a new target for cancer therapy

Oliver E. Bechter

Interdisciplinary strategies in metastatic cancer patients

D. Öfner

10 Years CECOG

Clinical importance of DNA repair inhibitors in cancer therapy

N. Hosoya, K. Miyagawa

Clinical implications of DNA repair genetic alterations in cancer

L. Gossage, M. Mohammed, S. Madhusudan

Disruption of telomere homeostasis as a new cancer treatment strategy

B.-S. Herbert

Role of interdisciplinary strategies in liver metastases

D. Öfner, W. Eisterer

Current role of interdisciplinary strategies in the treatment of pulmonary metastases

B. Akan, C. Bichler, D. Kandioler

Potentially curative strategies in peritoneal metastases

F. Kober, M. Karik, M. Hermann

Austrian Consensus on the surgical treatment of colorectal liver metastases

Dietmar Öfner, Thomas Grünberger, Wolfgang Eisterer

Challenges and pitfalls in HNPCC: a pedigree of an Austrian HNPCC family beyond four generations!

T. Winder, A. Mündlein, K. Gasser, G. Lingg, J. Walser, J. Karner-Hanusch, K. Dirschmid, H. Drexel, A. Lang

The expression of EGFR, HER2 and EpCam in Head and Neck squamous cell carcinomas

V. H. Schartinger, J. Schmutzhard, M. Wurm, I. M. Schwentner, P. Obrist, W. Oberaigner, G. M. Sprinzl

Lung cancer under 40

Matjaz Zwitter

Announcement